Ver ítem 

Mostrar el registro sencillo del ítem

Artículo

Opened Access
SEOM clinical guidelines in metastatic breast cancer 2015

dc.creatorGavilá, J.es
dc.creatorLopez-Tarruella, S.es
dc.creatorSaura, C.es
dc.creatorMuñoz, M.es
dc.creatorOliveira, M.es
dc.creatorCruz Merino, Luis de laes
dc.creatorMorales, S.es
dc.creatorAlvarez, I.es
dc.creatorVirizuela, J. A.es
dc.creatorMartin, M.es
dc.date.accessioned2024-04-03T14:53:15Z
dc.date.available2024-04-03T14:53:15Z
dc.date.issued2015
dc.identifier.citationGavilá, J., Lopez-Tarruella, S., Saura, C., Muñoz, M., Oliveira, M., Cruz Merino, L.d.l.,...,Martin, M. (2015). SEOM clinical guidelines in metastatic breast cancer 2015. Clinical and Translational Oncology, 17 (12), 946-955. https://doi.org/10.1007/s12094-015-1476-7.
dc.identifier.issn1699-048Xes
dc.identifier.issn1699-3055es
dc.identifier.urihttps://hdl.handle.net/11441/156648
dc.description.abstractMetastatic breast cancer is essentially an incurable disease. However, recent advances have resulted in a significant improvement of overall survival. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with meta static breast cancer to achieve the best patient outcomes based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommen dation the United States Preventive Services Task Force guidelines methodology was selected as reference.es
dc.formatapplication/pdfes
dc.format.extent9 p.es
dc.language.isoenges
dc.publisherSpringeres
dc.relation.ispartofClinical and Translational Oncology, 17 (12), 946-955.
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectMetastatic breast canceres
dc.subjectClinical guidelineses
dc.subjectChemotherapyes
dc.subjectHormonal therapyes
dc.subjectAnti-HER2 therapyes
dc.titleSEOM clinical guidelines in metastatic breast cancer 2015es
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicinaes
dc.relation.publisherversionhttps://link.springer.com/article/10.1007/s12094-015-1476-7es
dc.identifier.doi10.1007/s12094-015-1476-7es
dc.contributor.groupUniversidad de Sevilla. CTS151: Bioquímica médica.es
dc.journaltitleClinical and Translational Oncologyes
dc.publication.volumen17es
dc.publication.issue12es
dc.publication.initialPage946es
dc.publication.endPage955es

FicherosTamañoFormatoVerDescripción
SEOM....pdf484.8KbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Atribución 4.0 Internacional